Literature DB >> 18204248

Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis.

Junya Jia1, Guohua Ding, Jili Zhu, Cheng Chen, Wei Liang, Nicholas Franki, Pravin C Singhal.   

Abstract

BACKGROUND/AIM: In in vitro studies, angiotensin (Ang) II has been demonstrated to promote podocyte apoptosis. The present study evaluates the effects of Ang II infusion in rats on podocyte nephrin expression and apoptosis and the molecular mechanisms involved in Ang II-induced proteinuria and mesangial expansion.
METHODS: Sprague-Dawley rats were randomly assigned to receive either normal saline or Ang II (400 ng x kg(-1) x min(-1)) by means of a mini-osmotic pump for variable time periods. Systolic blood pressure and urinary protein and albumin excretion rate measurements were carried out on days 7, 14, 21, and 28. The animals were sacrificed on days 14 and 28 and evaluated for serum creatinine, renal pathological changes, podocyte apoptosis, renal nephrin mRNA, and protein expression.
RESULTS: The Ang II-infused rats developed hypertension and proteinuria. On day 14, the Ang II-infused rats showed narrowing of the slit diaphragm, an increase in podocyte nephrin mRNA and protein expression, and alterations in its distribution along the foot processes. On day 28, the Ang II-infused rats demonstrated the presence of apoptotic podocytes and decreased nephrin mRNA and protein expression. There was a negative correlation between nephrin expression and the numbers of apoptotic podocytes (r = -0.63, p < 0.05).
CONCLUSION: These results suggest that changes in nephrin expression may play a role in the pathogenesis of Ang II-induced podocyte apoptosis. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18204248      PMCID: PMC2630486          DOI: 10.1159/000113538

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  29 in total

Review 1.  Role of oxidative stress in angiotensin-induced hypertension.

Authors:  Jane F Reckelhoff; J Carlos Romero
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-04       Impact factor: 3.619

2.  Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.

Authors:  S Andersen; L Tarnow; P Rossing; B V Hansen; H H Parving
Journal:  Kidney Int       Date:  2000-02       Impact factor: 10.612

3.  Angiotensin II type 1 receptor blockade inhibits the development and progression of HIV-associated nephropathy in a mouse model.

Authors:  Noriyuki Hiramatsu; Keiju Hiromura; Tetsuya Shigehara; Takashi Kuroiwa; Hiroshi Ideura; Noriyuki Sakurai; Shigeru Takeuchi; Mai Tomioka; Hidekazu Ikeuchi; Yoriaki Kaneko; Kazue Ueki; Jeffrey B Kopp; Yoshihisa Nojima
Journal:  J Am Soc Nephrol       Date:  2007-01-17       Impact factor: 10.121

4.  Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.

Authors:  Sophie Doublier; Gennaro Salvidio; Enrico Lupia; Vesa Ruotsalainen; Daniela Verzola; Giacomo Deferrari; Giovanni Camussi
Journal:  Diabetes       Date:  2003-04       Impact factor: 9.461

5.  Fyn binds to and phosphorylates the kidney slit diaphragm component Nephrin.

Authors:  Rakesh Verma; Bryan Wharram; Iulia Kovari; Robin Kunkel; Deepak Nihalani; Kishore K Wary; Roger C Wiggins; Paul Killen; Lawrence B Holzman
Journal:  J Biol Chem       Date:  2003-03-31       Impact factor: 5.157

6.  Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome.

Authors:  S Doublier; V Ruotsalainen; G Salvidio; E Lupia; L Biancone; P G Conaldi; P Reponen; K Tryggvason; G Camussi
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

7.  Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling.

Authors:  Tobias B Huber; Björn Hartleben; Jeong Kim; Miriam Schmidts; Bernhard Schermer; Alexander Keil; Lotti Egger; Rachel L Lecha; Christoph Borner; Hermann Pavenstädt; Andrey S Shaw; Gerd Walz; Thomas Benzing
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

8.  Renal damage in the SHR/N-cp type 2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blocker.

Authors:  Marie-Luise Gross; Eberhard Ritz; Arne Schoof; Burkhard Helmke; Amy Parkman; Orien Tulp; Klaus Münter; Kerstin Amann
Journal:  Lab Invest       Date:  2003-09       Impact factor: 5.662

Review 9.  Treatment of diabetic nephropathy with angiotensin II receptor antagonist.

Authors:  Edmund J Lewis; Julia B Lewis
Journal:  Clin Exp Nephrol       Date:  2003-03       Impact factor: 2.801

10.  Angiotensin II induces apoptosis in rat glomerular epithelial cells.

Authors:  Guohua Ding; Krishna Reddy; Aditi A Kapasi; Nicholas Franki; Nora Gibbons; Balakuntalam S Kasinath; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2002-07
View more
  41 in total

1.  Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.

Authors:  Akihiro Fukuda; Larysa T Wickman; Madhusudan P Venkatareddy; Yuji Sato; Mahboob A Chowdhury; Su Q Wang; Kerby A Shedden; Robert C Dysko; Jocelyn E Wiggins; Roger C Wiggins
Journal:  Kidney Int       Date:  2011-09-21       Impact factor: 10.612

2.  Disparate effects of eplerenone, amlodipine and telmisartan on podocyte injury in aldosterone-infused rats.

Authors:  Wei Liang; Cheng Chen; Jing Shi; Zhilong Ren; Fengqi Hu; Harry van Goor; Pravin C Singhal; Guohua Ding
Journal:  Nephrol Dial Transplant       Date:  2010-08-20       Impact factor: 5.992

Review 3.  Oxidant Mechanisms in Renal Injury and Disease.

Authors:  Brian B Ratliff; Wasan Abdulmahdi; Rahul Pawar; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2016-04-26       Impact factor: 8.401

4.  Roles of Na⁺/H⁺ exchanger type 1 and intracellular pH in angiotensin II-induced reactive oxygen species generation and podocyte apoptosis.

Authors:  Ya Liu; Hirofumi Hitomi; Suwarni Diah; Kazushi Deguchi; Hirohito Mori; Tsutomu Masaki; Daisuke Nakano; Hiroyuki Kobori; Akira Nishiyama
Journal:  J Pharmacol Sci       Date:  2013-06-22       Impact factor: 3.337

5.  Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1.

Authors:  Zhilong Ren; Wei Liang; Cheng Chen; Hongxia Yang; Pravin C Singhal; Guohua Ding
Journal:  Cell Signal       Date:  2011-10-01       Impact factor: 4.315

Review 6.  Vitamin D receptor signaling in renal and cardiovascular protection.

Authors:  Yan Chun Li
Journal:  Semin Nephrol       Date:  2013-09       Impact factor: 5.299

7.  ANG II promotes autophagy in podocytes.

Authors:  Anju Yadav; Sridevi Vallabu; Shitij Arora; Pranay Tandon; Divya Slahan; Saul Teichberg; Pravin C Singhal
Journal:  Am J Physiol Cell Physiol       Date:  2010-05-19       Impact factor: 4.249

Review 8.  Reactive oxygen species: key regulators in vascular health and diseases.

Authors:  Qishan Chen; Qiwen Wang; Jianhua Zhu; Qingzhong Xiao; Li Zhang
Journal:  Br J Pharmacol       Date:  2017-07-11       Impact factor: 8.739

9.  Endothelin ET(B) receptors contribute to sex differences in blood pressure elevation in angiotensin II hypertensive rats on a high-salt diet.

Authors:  Wararat Kittikulsuth; Stephen W Looney; David M Pollock
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-06       Impact factor: 2.557

Review 10.  Oxidative stress in hypertension: role of the kidney.

Authors:  Magali Araujo; Christopher S Wilcox
Journal:  Antioxid Redox Signal       Date:  2013-04-30       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.